Membranous Nephropathy in Systemic Lupus Erythematosus: Long-Term Outcome and Prognostic Factors of 103 Patients

Seminars in Arthritis and Rheumatism

Volumn 41, Issue 5, 2012, Pages 642-651

  Moroni, Gabriella ^a   Quaglini, Silvana ^b   Gravellone, Luciana ^c   Gallelli, Beniamina ^a   Leoni, Antonio ^a   Messa, Piergiorgio ^a   Sinico, Renato Alberto ^c  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c SAN CARLO BORROMEO HOSPITAL   (Italy)

Author keywords

Lupus nephritis; Membranous nephropathy; Patient survival; Proliferative glomerulonephritis; Renal survival

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DNA ANTIBODY; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISONE;

ADULT; ARTICLE; CHRONIC KIDNEY FAILURE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE EXACERBATION; DRUG DOSE REDUCTION; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS NEPHRITIS; LUPUS MEMBRANOUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RETROSPECTIVE STUDY; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; BIOPSY; CREATININE; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METHYLPREDNISOLONE; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84859430476     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2011.08.002     Document Type: Article

References (41)

1. Donadio J.V., Hart G.M., Bergstralh E.J., Holley K.E. Prognostic determinants in lupus nephritis: a long-term clinicopathologic study. Lupus 1995, 4:109-115.
2. Neumann K., Wallace D.J., Azen C., Nessim S., Fichman M., Metzger A.L., et al. Lupus in the 1980s: III. Influence of clinical variables, biopsy, and treatment on the outcome in 150 patients with lupus nephritis seen at a single center. Semin Arthritis Rheum 1995, 25:47-55.
3. Huong D.L., Papo T., Beaufils H., Blétry O., Baumelou A., Godeau P., et al. Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center. Medicine 1999, 78:148-166.
4. Mok C.C., Wong R.W., Lau C.S. Lupus nephritis in Southern Chinese patients: clinicopathologic findings and long-term outcome. Am J Kidney Dis 1999, 34:315-323.
5. Pasquali S., Banfi G., Zucchelli A., Moroni G., Ponticelli C., Zucchelli P. Lupus membranous nephropathy: long-term outcome. Clin Nephrol 1993, 39:175-182.
6. Bakir A.A., Levy P.S., Dunea G. The prognosis of lupus nephritis in African-Americans: a retrospective analysis. Am J Kidney Dis 1994, 24:159-171.
7. Mercadal L., Montcel S.T., Nochy D., Queffeulou G., Piette J.C., Isnard-Bagnis C., et al. Factors affecting outcome and prognosis in membranous lupus nephropathy. Nephrol Dial Transplant 2002, 17:1771-1778.
8. Leaker B., Fairley K.F., Dowling J., Kincaid-Smith P. Lupus nephritis: clinical and pathological correlation. Q J Med 1987, 62:163-179.
9. Wang F., Looi L.M. Systemic lupus erythematosus with membranous lupus nephropathy in Malaysian patients. Q J Med 1984, 53:209-226.
10. Sloan R.P., Schwartz M.M., Korbet S.M., Borok R.Z. Long-term outcome in systemic lupus erythematosus membranous glomerulonephritis. Lupus Nephritis Collaborative Study Group. J Am Soc Nephrol 1996, 7:299-305.
11. Bono L., Cameron J.S., Hicks J.A. The very long-term prognosis and complications of lupus nephritis and its treatment. QJM 1999, 92:211-218.
12. Appel G.B., Cohen D.J., Pirani C.L., Meltzer J.I., Estes D. Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization. Am J Med 1987, 83:877-885.
13. Sun H.O., Hu W.X., Xie H.L., Zhang H.T., Chen H.P., Zeng C.H., et al. Long-term outcome of Chinese patients with membranous lupus nephropathy. Lupus 2008, 17:56-61.
14. Adler S.G., Johnson K., Louie J.S., Liebling M.R., Cohen A.H. Lupus membranous glomerulonephritis: different prognostic subgroups obscured by imprecise histologic classifications. Mod Pathol 1990, 3:186-191.
15. Schwartz M.M., Kawala K., Roberts J.L., Humes C., Lewis E.J. Clinical and pathological features of membranous glomerulonephritis of systemic lupus erythematosus. Am J Nephrol 1984, 4:301-311.
16. Gladman D.D., Ibanez D., Urowitz M.B. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002, 29:288-291.
17. Weening J.J., D'Agati V.D., Schwartz M.M., Seshan S.V., Alpers C.E., Appel G.B., et al. Classification of glomerulonephritis in systemic lupus erythematosus revisited. Am Soc Nephrol 2004, 15:241-250.
18. Austin H.A., Muenz L.R., Joyce K.M., Antonovych T.A., Kullick M.E., Klippel J.H., et al. Prognostic factors in lupus nephritis. Contributions of renal histological data. Am J Med 1983, 75:382-391.
19. The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. Arthritis Rheum 2006, 54:421-432.
20. Moroni G., Quaglini S., Gallelli B., Banfi G., Messa P., Ponticelli C. The long-term outcome of 93 patients with proliferative lupus nephritis. Nephrol Dial Transplant 2007, 22:2531-2539.
21. Najafi C.C., Korbet S.M., Lewis E.J., Schwartz M.M., Reichlin M., Evans J. Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 2001, 59:2156-2163. Lupus Nephritis Collaborative Study Group.
22. Wong S.N., Chan W.K., Hui J., Chim S., Lee T.L., Lee K.P., et al. Membranous lupus nephritis in Chinese children-a case series and review of the literature. Pediatr Nephrol 2009, 24:1989-1996.
23. Dooley M.A., Hogan S., Jennette C., Falk R. Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network. Kidney Int 1997, 51:1188-1195.
24. Ward M.M. Association between physician volume and in-hospital mortality in patients with systemic lupus erythematosus. Arthritis Rheum 2005, 52:1646-1654.
25. Moroni G., Maccario M., Banfi G., Quaglini S., Ponticelli C. Treatment of membranous lupus nephritis. Am J Kidney Dis 1998, 31:681-686.
26. Rivera T.L., Belmont H.M., Malani S., Latorre M., Benton L., Weisstuch J., et al. Current therapies for lupus nephritis in an ethnically heterogeneous cohort. J Rheumatol 2009, 36:298-305.
27. Radhakrishnan J., Moutzouris D.A., Ginzler E.M., Solomons N., Siempos I.I., Appel G.B. Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis. Kidney Int 2010, 77:152-160.
28. Chan T.M., Li F.K., Wong R.W., Wong K.L., Chan K.W., Cheng I.K. Sequential therapy for diffuse proliferative and membranous lupus nephritis: cyclophosphamide and prednisolone followed by azathioprine and prednisolone. Nephron 1995, 71:321-327.
29. Chan T.M., Li F.K., Hao W.K., Chan K.W., Lui S.L., Tang S., et al. Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression. Lupus 1999, 8:545-551.
30. Mok C.C., Ying K.Y., Lau C.S., Yim C.W., Ng W.L., Wong W.S., et al. Treatment of pure membranous lupus nephropathy with prednisone and azathioprine: an open-label trial. Am J Kidney Dis 2004, 43:269-276.
31. Mok C.C., Ying K.Y., Yim C.W., Ng W.L., Wong W.S. Very long-term outcome of pure lupus membranous nephropathy treated with glucocorticoid and azathioprine. Lupus 2009, 18:1091-1095.
32. Tam L.S., Li E.K., Szeto C.C., Wong S.M., Leung C.B., Lai F.M., et al. Treatment of membranous lupus nephritis with prednisone, azathioprine and cyclosporin A. Lupus 2001, 10:827-829.
33. Kasitanon N., Petri M., Haas M., Magder L.S., Fine D.M. Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concurrent proliferative disease: a retrospective study of 29 cases. Lupus 2008, 17:40-45.
34. Spetie D.N., Tang Y., Rovin B.H., Nadasdy T., Nadasdy G., Pesavento T.E., et al. Mycophenolate therapy of SLE membranous nephropathy. Kidney Int 2004, 66:2411-2415.
35. Austin H.A., Illei G.G., Braun M.J., Balow J.E. Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy. J Am Soc Nephrol 2009, 20:901-911.
36. Swan J.T., Riche D.M., Riche K.D., Majithia V. Systematic review and meta-analysis of immunosuppressant therapy clinical trials in membranous lupus nephritis. J Investig Med 2011, 59:246-258.
37. Moroni G., Quaglini S., Maccario M., Banfi G., Ponticelli C. "Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int 1996, 50:2047-2053.
38. Mosca M., Bencivelli W., Neri R., Pasquariello A., Batini V., Puccini R., et al. Renal flares in 91 SLE patients with diffuse proliferative glomerulonephritis. Kidney Int 2002, 61:1502-1509.
39. El Hachmi M., Jadoul M., Lefèbvre C., Depresseux G., Houssiau F.A. Relapses of lupus nephritis: incidence, risk factors, serology and impact on outcome. Lupus 2003, 12:692-696.
40. Illei G.G., Takada K., Parkin D., Austin H.A., Crane M., Yarboro C.H., et al. Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term follow-up of a cohort of 145 patients participating in randomized controlled studies. Arthritis Rheum 2002, 46:995-1002.
41. Mok C.C., Ying K.Y., Tang S., Leung C.Y., Lee K.W., Ng W.L., et al. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis. Arthritis Rheum 2004, 50:2559-2568.